Skip to main content
Veterinary Medicines

POULVAC TRT LYOPHILISAT POUR SUSPENSION POUR LA VACCINATION DES DINDES POUR ADMINISTRATION PAR NEBULISATION OU PAR GOUTTE OCULAIRE OU NASALE

Not authorised
  • Turkey rhinotracheitis virus, strain Clone K, Live

Product identification

Medicine name:
POULVAC TRT LYOPHILISAT POUR SUSPENSION POUR LA VACCINATION DES DINDES POUR ADMINISTRATION PAR NEBULISATION OU PAR GOUTTE OCULAIRE OU NASALE
POULVAC TRT
Active substance:
  • Turkey rhinotracheitis virus, strain Clone K, Live
Target species:
  • Turkey
Route of administration:
  • Ocular use
  • Intranasal use
  • Oculonasal use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain Clone K, Live
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Ocular use
    • Turkey
  • Intranasal use
    • Turkey
  • Oculonasal use
    • Turkey
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CD01
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:
  • Boîte de 1 flacon de 2000 doses
  • Boîte de 1 flacon de 5000 doses
  • Boîte de 10 flacons de 1000 doses
  • Boîte de 10 flacons de 2000 doses
  • Boîte de 10 flacons de 5000 doses
  • Boîte de 1 flacon de 1000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Spain S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • (AEMPS)
Authorisation number:
  • 1378 ESP
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0412/001/MR
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."